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Introduction 
 
“It is comforting to think that it is not possible to defend involuntary 
euthanasia, forced sterilization, and genocide in moral terms. It is 
comforting to think that anyone who espouses racist, eugenic ideas 
cannot be a competent, introspective physician or scientist.  Such 
beliefs are especially comforting to ethicists. Nazi medical crimes 
show that each of these beliefs is false” 
-Arthur Caplan, How Did Medicine Go So Wrong? 
 
 The purpose of this thesis is not to preach but to examine.  The following 
pages attempt to provide a picture not only of some of the darkest moments in 
medical ethics but also of the events occurring after-the attempts to address the 
actions of the Nazi doctors and prevent any future crimes against ethics and 
humanity.  The world of biomedical research is seventy years and millions of 
innovations past the events of World War II. As a result, the experiments in 
concentration camps may seem but a blemish of the past.  This work aims to 
examine the interplay of circumstances that allowed for these experiments to 
happen, taking at face value evidence asserting that not all of the doctors were 
sadists or mad men and that many felt their actions and experiments were 
ethically justified.   
A study of the history of medical ethics reveals that certain conditions and 
pressures place both doctors and patients in situations that can, and often do, 
result in breaches of medical ethics. The experiments conducted during World 
War II provide some of the most extreme examples in breaches of human rights 
and ethics the world has so far seen.There is no benefit in considering the Nazi 
experiments as “other” or irrelevant. The greatest good that can come out of 
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these atrocities is the lessons they have to teach about what plays into and 
creates a hostile research environment.  Before the rise of Hitler and the Nazi 
party, Germany was at the forefront of both medical research and medical ethics.  
It is important to remember this while examining what factors, both culturally and 
politically, transformed one of the most forward moving and medically advanced 
countries into a genocidal machine.   
The great irony of the actions perpetrated by Nazi doctors in concentration 
camps during the second world war is the fact that, only ten years previously, 
Germany had been actively developing and defining principles to guide ethical 
biomedical research.  Early in the twentieth century, the issue of patient rights in 
experimentation was brought to the forefront of the Prussian Government as a 
result of the experiments of Albert Neisser. In his search for a vaccine for 
syphilis, Neisser injected cell free serum into his patients without their consent, 
causing many to contract the disease.  Revelations of Neisser’s experiments 
were met with general uproar and debate both within and outside of the medical 
community. (Baumslag, 2005, p. 131)  In 1928, the Berlin Medical Association 
issued a statement stating that although they did not agree with a legal limit 
being placed on scientific research, 
 “Any trial on human must be limited to what is absolutely 
necessary, must be well grounded theoretically and scientifically, 
and must be well defined biologically...for the well-being of the 
patient is more important than science.  Moreover, medical ethics 
commands that the patient or a legal representative be informed of 
the spirit and purpose of the particular therapeutic test” (Winau, 
2007, p. 53).  
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 The debates over medical ethics continued into the 1930s.  During this time, 
Emil Abderhalden published Ethiks, the first international physician-run journal to 
focus on ethics.  In a 1930 poll taken by Abderhalden, the German medical 
community was shown to be split on the legitimacy and need for biomedical 
experimentation. (Frewer, 2007, p. 31)  In 1931, the Reich government published 
the “Guidelines for New Therapy and Human Experimentation”.  The document 
stated,  
“Undertaking any test without informed consent is impermissible 
under any circumstances. Any test on humans that could have 
been replaced by a test on animals is to be rejected...Experiments 
performed on children or adolescents under the age of 18 are not 
allowed if they will endanger the welfare of the child or adolescent 
in the slightest. Experiments on the dying are incompatible with the 
principles of medical ethics and thus not permitted” (Winau, 2007, 
p. 54).   
 
It is clear that even in its earliest inception on, the concepts of informed consent 
of the patient were already under discussion in the realm of the bioethics. The 
“Guidelines” were repeated and cited in future ethical documents. They are more 
stringent than those set forth by most bioethical documents since this time. 
However, while they clearly enumerated many expectations for human 
experimentation, they were later claimed by defendants at the Nuremberg Trials 
(the tribunal held by the U.S. Trials System at the close of World War II)  to be 
“relative” and “not the standard” for German medical practices. (Grodin, 1992b, 
p.128) 
 The general conception of medical professions at the time was that 
physicians were to be given complete authority over their own decisions and did 
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not need supervision.  Though the bioethical movement did take root in 
Germany, it has been argued by historians that the development was too 
philosophical, and the confidence in the collective morality of both physicians and 
the national community was, “Ultimately the cause and internal logic of an ‘ethics 
without humanity…[which] paved the way by justifying and shaping the events 
that unfolded” (Frewer, 2007, p. 30).  The rise of the National Socialist movement 
led to “An ethical decline in physicians’ perception of their professional identity” 
(Frewer, 2007, p. 36).  This was reinforced by concepts like “lives not worth 
living”, a term that was repeated often in Nazi propaganda and which played a 
central role in justifying many atrocities committed under the Nazi regime.  During 
this time, Viktor von Weizsacker, a physician/philosopher who wrote extensively 
on eugenics, stated, “If the physician presupposes there to be worth in a given 
worldly and temporal life, but one void of eternal value, then that merely temporal 
worth can be so low that the life in question deserves annihilation” (Bohme, 2007, 
p. 24).  
 In his book, When Medicine Went Mad, prominent bioethicist Arthur 
Caplan argues that the Nazi operation was made possible because of the work of 
German scientists; educated men and women who were, in one way or another, 
able to sufficiently morally justify their actions despite their “degree of civilization”. 
(1992b, p. 157)  In her analysis of the events, Ruth Macklin writes, “The Nazi era 
in general, and the behavior of Nazi doctors in particular, serve to show that 
despite a general historical progression toward greater humaneness and 
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humanity, egregious regressions and moral backsliding have occurred” (1992, p. 
243).  
 It is with this background in mind that I begin the investigation into the 
history of bioethics in the United States.  The second chapter of this thesis 
provides a summary of some of the experiments done both on behalf of the 
German government and at the whim of the Nazi researchers in concentration 
camps during the Second World War.  Most of the accounts come from records 
of the doctors’ diaries or from first hand testimonies provided by survivors and 
later summarized into works about these events.  Chapter three outlines three 
documents of significance to the progression of medical ethics:  The Nuremberg 
Code, The Declaration of Helsinki, and the Belmont Report.  In addition, the 
chapter examines the concept of informed consent, how it is presented in each 
document and what significance it holds to the justification and creation of ethical 
biomedical research.This section phrases the argument with the same ethical 
terminology that is frequently used to philosophically justify the existence of 
biomedical research as a whole. Chapter four addresses the state of current 
affairs. It outlines the IRB process used by the United States, focusing on the 
ways that the process deviates from previous guidelines as well as the methods 
it employs to address the problems currently encountered in biomedical 
research. Though dense, this process forms the cornerstone for all analysis 
about the efficacy of current policy.   Chapter five looks at recent research about 
the state of ethics in modern biomedical research.  It uses data from empirical 
and behavioral studies on the current research environment in order to assess 
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areas of concern and examine how well the modern IRB process addresses 
present concerns surrounding the state of ethics in biomedical research.  
Chapter six summarizes and discusses the significance of the information 
presented in the previous chapters, drawing connections between past events 
and modern concerns in order to emphasize the role a historical understanding of 
research ethics can have in the development of future policies and systems of 
ethics.   The epilogue briefly discusses problems presented by the political 
system, specifically those conditions that arise during times of upheaval and 
violence.   
 Biomedical research contains within it an inherent tension. A researcher is 
required to negotiate a careful balance between protecting the rights of the 
individual subject and conducting experiments for the benefit of “the greater 
good”.  The negotiation of these two elements is both challenging and crucial to 
ethical research.  As stated in the Massachusetts General Hospital’s Guiding 
Principles for Human Studies of 1981, “A study is ethical or not at its inception.  It 
does not become ethical because it succeeds in producing valuable data” 
(Angell, 1992, p.278).  If the ultimate goal of biomedical research is the pursuit 
and development of procedures and technologies to benefit mankind, doing so 
unethically undermines the entire process.  In this case the ends cannot not 
justify the means; individual inviolability must have equal weight with the greater 
good. 
 It is for this reason that the history of bioethics is essential to modern 
medical research.  The events that unfolded both during and following World War 
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II reveal the frequent failings of biomedical research to successfully navigate this 
tension.  As a result, many have been harmed in a way that goes against the 
purpose of medicine. In order to avoid similar occurrences, knowledge of these 
events and the factors that lead to them must be imparted to all involved in 
research. History shows that bioethical policy acquires its strength through the 
degree that researchers adhere to it.  It is therefore essential that new scientists 
learn and appreciate the extensively scarred history of their profession, and the 
implications this has on their own research. The preservation of the integrity of 
the subject is dependent on the integrity of the researchers.   
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Summary of Concentration Camp Experiments and Doctors  
 
“He wasn’t a monster...none of the Nazi Doctors were, 
you know -but merely a fallible and corruptible human 
being”  
-Dr. Magda V. on Dr. Josef Mengele 
 
In his reports, Dr. Sigmund Rascher, a captain of the medical service of 
the German airforce, described one of the high altitude experiments that was 
conducted at the Dachau concentration camp during the war,  
“It was a continuous experiment without oxygen at a height of 12 
kilometers conducted on a 37-year-old Jew in good general condition.  
Breathing continued up to 30 minutes.  After 4 minutes the experimental 
subject began to perspire and wiggle his head, after 5 minutes cramps 
occurred, between 6 and 10 minutes breathing increased in speed and the 
experimental subject became unconscious; from 11 to 30 minutes 
breathing slowed down to three breaths per minute, finally stopping 
altogether.   
 
Severest cyanosis developed in between and foam appeared at the 
mouth. 
 
At 5 minute intervals electrocardiograms from three leads were written.  
After breathing had stopped Ekg was continuously written until the action 
of the heart had come to a complete standstill.  About ½ hour after 
breathing had stopped, dissection was started” (Katz, 1992b, p. 233). 
 
The high altitude experiments were just one type of experiment sponsored by the 
Ahnenerbe (ancestral heritage) office of the SS, an agency created by Heidrich 
Himmler in 1939 to “develop historical and scientific studies of the Nordic Indo-
Germanic race...and combine the Gestapo mission of controlling Germany’s 
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intellectual life with Himmler’s visionary ideas”  (Lifton, 1986,  p.286).  The idea 
for these particular experiments was proposed by Dr. Rauscher in 1941. He 
wrote to Himmler requesting that subjects be put at his disposal on which to 
conduct these experiments.  Rauscher was given the go ahead and a movable 
pressure chamber was placed at Dachau that allowed experimenters to simulate 
the rapid changes in pressure that occur when humans fall great distances 
without parachute and oxygen.  (Taylor, 1946, p.71)  The subjects chosen for the 
study were at first Poles and Russians, however, later on “Jewish professional 
criminals”, those guilty of racial shame (marriage or intercourse between Aryans 
and non-Aryans) were found to be in greater supply.  (Taylor, 1946, p. 73)  
 After the conclusion of the high altitude experiments, inmates at the 
Dachau concentration camp became subjects in freezing experiments that were 
also conducted at the bequest of the German Air Force.  (Taylor, 1946, p. 74)  
These experiments aimed to discover possible ways to rewarm German pilots 
who had been forced to land in the cold North Sea.  Subjects were immersed in 
water ranging from 2 to 12 degrees Celsius for 3 hours at a time, as well as 
made to stand naked in below freezing temperatures for up to 14 hours.  
Different methods were then tested in order to determine the best method of 
rewarming.  Experiments were conducted with and without narcotics; attempts at 
rewarming included placing the body between two naked women and throwing 
the subject into boiling water.  (Taylor, 1946, p. 74) Documentation for the study 
reveals that very little scientific process was observed.  Factors such as subject 
age, weight and height were not recorded; EKGs provided the only assessments 
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of cardiac activity and no measurements were taken during immersion in cold 
water.  Nonetheless, a report referred to as the Dachau Comprehensive Report 
was prepared by Dr. Rascher for presentation of the research.  (Berger, 1990) A 
comprehensive analysis of the experiments was compiled by Dr. Leo Alexander 
after the war that revealed many variables were not assessed or considered 
during the experiments.  A more contemporary analysis conducted by historian 
Dr. Robert Berger also concluded that the experiments do not provide reliable 
evidence stating, “In summary, the basic information essential for documenting 
an orderly experimental protocol and evaluating the results is not provided. We 
know enough, however, to conclude that the methods of study were clearly 
defective” (1990). Though this is still a topic of debate, it has been strongly 
argued that the results acquired in the experiments are scientifically unreliable. 
There is considerable evidence that despite their knowledge of the scientific 
process, the majority of the doctors performing these tests failed to create 
experiments that would appropriately and accurately produce data. (Berger, 
1990) During the Doctor’s Trial, the prosecution argued, “The moral 
shortcomings of the defendants and the precipitous ease with which they decided 
to commit murder in quest of “scientific results” dulled also that scientific 
hesitancy, that thorough thinking-through, that responsible weighing of every 
single step which alone can ensure scientifically valid results” (Taylor, 1946, p. 
91). 
 Other Nazi experiments included attempts to make seawater drinkable, to 
find vaccines for malaria and typhus, experiments with sulfanilamide (a chemical 
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compound that was thought to clot blood), mustard gas and other poisons, 
sterilization experiments and the creation of a “Jewish skeleton collection”. 
(Taylor, 1946, p. 84)  Each experiment was conducted with a similar lack of 
regard for patient safety.  If the subjects survived the experiments, they were 
often euthanized so that their bodies could be dissected for further research.  
Many subjects were purposely infected with diseases such as typhus and malaria 
in order to perform experiments on them.  In studies of the coagulation of the 
blood, inmates were fired upon to simulate battlefield wounds and then treated 
with polygal and sulfanilamide (compounds whose properties as blood clotting 
agents were being tested).  Any side effects, diseases, or infections that 
developed as a result of these experiments were left untreated. (Taylor, 1946, p. 
77)  
 The motivation behind these experiments varied.   Some reflected the 
personal interests of the doctors presiding over them.  Dr. Eduard Wirths, the 
chief SS doctor at Auschwitz, conducted trials that studied pre-cancerous 
conditions of the cervix. Many were commissioned by Himmler in order to serve 
the needs of the German government.  (Lifton, 1986,  p. 269) For the most part, 
the experiments were performed with nationalistic intentions. Sterilization and 
castration experiments conducted by Drs. Clauberg and Schumann in Auschwitz 
were encouraged as a direct expression of racial theory and policy.  (Lifton, 
1986, p. 269)   In a letter to Himmler in 1941, Dr. Adolf Pokorny, a retired 
German medic wrote, “The thought alone that 3 million Bolsheviks, at present 
German prisoners, could be sterilized so that they could be used as laborers but 
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be prevented from reproduction opens the most far-reaching perspectives” 
(Lifton, 1986, p. 275).  
Despite the violence involved in the majority of the experiments, records 
show that Nazi doctors still viewed their work as scientific.  Heidrich Himmler, the 
man in charge of commissioning most trials, saw himself as “a patron of science”. 
He was, “The pseudo-medical scientist par excellence, the personal and 
ideological epitome of the healing-killing reversal” (Lifton, 1986, p. 279).  The 
doctors that conducted these experiments were established medical 
professionals.  They identified the opportunities for unrestrained research made 
possible by the availability of bodies and lack of oversight.  Dr. Robert Lifton 
wrote of one physician, Dr. Helmuth Vetter, who was employed by the Bayer 
Group and ran medical trials for them in several concentration camps, “He found 
in Auschwitz a testing area where he need not be restrained either by 
compunctions about harming or killing research subjects, or by rigorous 
judgments about therapeutic effects” (1986, p. 292).   SS doctors and medical 
students used concentration camp prisoners to gain surgical experience by using 
those afflicted with various diseases as “practice” to hone their skills.  Lifton 
states,  
“In the absence of ethical restraint, one could arrange exactly the 
kind of surgical experience one sought, on exactly the appropriate 
kinds of “cases” at exactly the time one wanted.  If one felt 
Hippocratic twinges of conscience, one could usually reassure 
oneself that, since all of these people were condemned to death in 
any case, one was not really harming them. Ethics aside, and apart 
from a few other inconveniences, it would have been hard to find so 
ideal a surgical laboratory” (1986, p. 295).  
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Records of researcher’s diaries show that many of them could identify the fault in 
the events but accepted it as reality and felt themselves detached from the 
proceedings.  Dr. Johann Kremer, a doctor at Auschwitz, kept a diary that 
alternately spoke of the “routine” horrors he experienced in the concentration 
camp life and what he had eaten for dinner. Accounts of Dr. Josef Mengele, 
infamous both for his experiments and for his success in evading capture 
following the war, provide a clear example of the dichotomy between civilized 
scientist and murderer that manifested itself in many of the Nazi physicians.   
Mengele was trained at the University of Munich; though he did not join 
the Nazi party until 1937, his research and attitude towards his research reflect 
his ardent faith in the Nazi doctrine.  He achieved infamy very soon after the war 
as stories from former subjects, as well as documentation from Auschwitz began 
to expose his role in the experiments conducted at the camp. In addition to being 
largely in charge of the selection process (a process in which he was asked to 
choose which of the inmates would be sent to the gas chambers on a certain 
day), Mengele conducted “twin experiments” in which he attempted to 
understand the role heredity played in different traits in order to reinforce Nazi 
ideals of the superiority of the Aryan Race. (Lifton, 1986, p. 352)  The stories told 
by some of his former subjects depict a man capable of heartless murder as well 
as countless other crimes.  However, other accounts given by former colleagues 
and prisoners paint him as less of a monster. A fellow doctor at the camp stated 
that Mengele showed himself to be, “Cultivated, pleasant, and knowledgeable in 
discussions not only on medical subjects but about literary questions, even 
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Flaubert” (Lifton, 1986, p. 371). Mengele’s intense interest in twins resulted in 
their receiving special treatment in the camps.  He was seen showing kindness 
and favoritism to certain pairs of twins, giving them rides in his cars and bringing 
them presents.  However, he also was observed emotionlessly killing those who 
he deemed no longer useful, or whom he decided would be of better use 
dissected.  (Lifton, 1986, p. 353) He was described as a man who liked to be in 
control, who was passionate about his research; a “duality of affection and 
violence”.  (Lifton, 1986, p. 355) One prisoner doctor questioned, “Was he a kind 
man, good with children...who was only driven to do the things he did by his 
passion for research?  Or was he a monster who only plays a role with the 
children to hide his game better, to get his ends more easily?” (Lifton, 1986, p. 
374) This wavering doubt about the nature of Mengele’s character applied to his 
peers’ opinions of his research practices and scientific integrity as well.  
There were many doctors and peers at Auschwitz who respected Mengele 
and his passion for his research.   He was described by an assistant working at 
the camp as, “Having a sense of legitimacy of his method and of his having been 
a man with a genuine ‘scientific background’ who was ‘absolutely capable of 
doing serious and appropriate scientific work” (Lifton, 1986, p. 365).   Mengele 
was passionate about his work, however, his conception of the scientific process 
involved demanding absolute control over his research environment.  He is said 
to have been stubborn-a man whose purpose in his experiments was the search 
for proof for his preconceived values and beliefs. He often refused to 
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acknowledge any evidence of contradiction to his expected results.  (Lifton, 1986, 
p. 370)  
 Despite his infamy, by all accounts, Mengele does not represent 
the worst of the Nazi doctors.  Instead, he is an example in large part of a man 
who fell naturally into the mold of a concentration camp doctor-someone who 
was perfectly fitted to the environment and conditions of the Auschwitz camp and 
the Nazi government.  In concluding his analysis of Mengele, Robert Lifton 
states,  
“In the camp he could be a visionary ideologue, an efficiently 
murderous functionary, a “scientist” and even a “professor,” an 
innovator in several areas, a diligent careerist, and, above all, a 
physician who became a murderer.  He reveals himself as a man 
and not a demon, a man whose multifaceted harmony with 
Auschwitz can give us insight into-and make us pause before-the 
human capacity to convert healing into killing” (1986, p. 383). 
 
Perhaps one of the most significant aspects of Mengele’s story is his ability to 
completely detach from his patients while maintaining parts of his humanity.  His 
ability to show affection, to hold intelligent conversation, to interact on an 
everyday basis was not impeded by his frequent murders of children, nor his 
“god-like” role in determining those sent to the gas chambers. Mengele’s training 
as a doctor occurred during a time when the topics of ethics in human 
experimentation were being actively discussed in the German medical field.  It is 
unlikely these principles would have been unknown to him. However, the 
opportunities, resources, and lack of oversight he received while working as a 
doctor in Auschwitz caused him to set all of this aside.   
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It is important to keep in mind when studying these events that the men 
responsible for the experiments at Nazi concentration camps during World War II 
represented many of the established members of the German medical 
community. The defendants at the Doctor’s Trial included the head of the 
University of Berlin Department of Surgery, acclaimed military medical 
administrators, specialists in the fields of public health and tropical diseases.  
(Taylor, 1992, p. 87)  Many of the men had already reached the peak of their 
profession.   Though some of them, such as Clausberg and Kremer, seem to 
have been universally disliked for their attitudes both towards their subjects and 
their peers, others got very different and far more mixed reviews. They were not 
monsters, bred from a different cloth and living in a separate world.  The 
horrifying nature of these events has sometimes caused them to be viewed as 
“irrelevant” to modern medical research; this is a mistake. As Arthur Caplan 
explains in his book, 
 “It is comforting to believe that health care professionals who have 
pledged an oath to ‘do no harm’ and who are minimally concerned 
with the morality of their own conduct could not kill babies or 
conduct brutal, often lethal, experiments on starving inmates in 
concentration camps...It is comforting to think that anyone who 
espouses racist, eugenic ideas cannot be a competent, 
introspective physician or scientist.  Such beliefs are especially 
comforting to ethicists.  Nazi medical crimes show that each of 
these beliefs is false” (1992b, p. 55) 
 
During the Doctor’s Trial at Nuremberg, the German researchers showed little 
remorse for their actions.  Instead, they offered ethical arguments for the 
research, explaining that the rules during war are different and they believed their 
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experiments justified as they were acting in the interest of the “greater good”. The 
events that transpired in Dachau and Auschwitz are not foreign, they are not the 
work of creatures unfit for the “modern world”. The men involved were not 
monsters but educated German physicians. Their actions have permanently 
stained the history of biomedical research.   
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The Nuremberg Code and Beyond 
 
“One has to strive toward obtaining an international basis to 
represent the present international opinion on human experiments, 
one which for decades, if not for centuries, will form the criterion for 
the permissibility of human experiments.  We, as jurists, can only 
render a service to the development of medical science and 
therewith to humanity if we endeavor to establish an 
incontrovertibly clear view of today’s international opinion on human 
experiments”  
-Closing Brief, Nuremberg Trial 
 
 Throughout the second half of the 20th century, following the publication 
of the many violations of human rights committed during World War II, there were 
several documents published whose goals were not only to condemn the actions 
of the Nazi Doctors but to also set new standards for the rights of the individual in 
human experimentation and reaffirm the commitment to repercussions from the 
international community for any future violations of human rights.  In the realm of 
bioethics and human experimentation, three documents stand out in the strength 
of the statements they made as well as the impacts that they had on the 
formation of future medical ethics policies. (A. Caplan, personal communication, 
December 10, 2014)  These three documents, the Nuremberg Code, the 
Declaration of Helsinki, and the Belmont Report will form the basis of my 
examination of the processes that have led to the IRB process.  
  These three documents represent the foundations of modern biomedical 
ethics.  When examining these documents, their contents, and the effects they 
have had, both directly and indirectly, on the formation of the IRB process, it is 
important to consider them within a historical context.  
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 The impetus behind the creation of the Nuremberg Code is perhaps the 
most obvious.  Following the conclusion of the war, a series of military Tribunals 
were held by the Allied forces in order to assess and prosecute the crimes 
committed by leaders of the Nazi party during the war.  Though ostensibly a 
collective effort, these trials were held in the U.S. occupation zone of Nuremberg 
and were conducted by the U.S. Trials Court.  (Annas & Grodin, 1992, p.7) One 
of these trials, United States of America v. Karl Brandt et al. is known as the 
Doctors’ Trial and focused on the crimes committed by concentration camp 
doctors during the war. There were 23 defendants, all German and the majority 
doctors. The tribunal convened 139 times after the indictment and arraignment of 
the defendants.  At the conclusion of the trial, seven were issued the death 
sentence. (Annas, Grodin, 1992, p. 5) In addition, the verdict included a set of ten 
principles of medical ethics in the area of human experimentation.  These 
principles are now known as the Nuremberg Code.   
The Code was issued as part of the judicial process at the conclusion of 
the Doctors’ Trial at Nuremberg. (Annas, Grodin, 1992, p. 6)  During the trial, the 
defendants argued that there was a large degree of “relativism” in codes of ethics 
concerning human research.  (Grodin, 1992, p. 128) Although, as it has already 
been discussed, a code of ethics did exist in Germany at the time, because it 
was not “universal” the Nazi doctors believed it did not confer the same 
legitimacy as other legal documents.  It was with this argument in mind that the 
Nuremberg Code was created.  Though it was overseen by the U.S. Trials Court, 
it was declared to be the first “Universal Code of Ethics”.    
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Today, the Nuremberg Code is largely recognized as “A hallmark for all 
subsequent discourse on the ethics of human experimentation” (Grodin, 1992, p. 
122).  However, while it is seen to have great ideological significance in the world 
of medical ethics, the code has been criticized for the lack of impact the 
document has actually had on medical experimentation. As Sharon Perley, Sev 
Fluss, Zbigniew Bankowski and Francoise Simon pointed out in their essay on 
the Code, “A set of “universal principles”, with no legal or professional authority, 
is successful only if researchers choose to abide by them” (1992, p. 157).    In his 
book, Justice at Nuremberg, Ulf Schmidt claims,  
“By 1953 US governments officials were fully aware of the fact that 
the Code constituted part of international law and that a violation of 
its principles, irrespective of national security requirements, could 
undermine the self-proclaimed moral superiority of the Western 
governments”  (2004, p. 278). 
 
However, despite this, the medical profession did not view it as significant. 
The Nuremberg Code has been described as inadequate.  Many doctors 
resented the implications it made and were indignant to find themselves 
compared to the Nazi doctors and to be asked to follow ethical laws that they 
saw as “obvious”. The Code was described as, “A good code for barbarians but 
an unnecessary code for ordinary physician-scientists” (Katz 1992b, p. 228).  
Even by the 1950s, the lack of appreciation and respect for the principles of the 
Nuremberg code can be seen in research.  (Annas, 1992, p. 218) It was believed 
that, “Researchers generally regarded the Nuremberg Code as a set of principles 
appropriate for moral monsters, not for democratically minded American 
physicians” (Stark, 2012,  p.104).  There was an idea that Nazi doctors and their 
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actions were unique in the history of medicine, and it was therefore insulting to 
even compare them to current research.  In addition, doctors objected to the 
judicial nature of the Code, arguing that it was created by men who had no 
knowledge of the realities of the medical profession. (Glantz, 1992, p. 197) 
Needless to say, there was considerable resistance to the Nuremberg Code and 
its adoption in the field of medical research.  Those involved in policy formation in 
the international community acknowledged these problems with the code, 
however, also agreed that the actions of Nazi doctors during World War II were 
too significant to the world of medicine to be ignored.  If doctors would not 
respect the Nuremberg Code, something else must be created.  There was a 
need for professional guidelines designed by physicians for physicians (Perley et. 
al, 1992, p. 157). 
The Declaration of Helsinki represents the World Medical Association’s 
response to the Nuremberg code. The document, originally published in 1964, 
lists the principles its creators believe must be observed within the sphere of 
human experimental research. Noting the judicial nature of the Nuremberg code 
and the stringent limits it placed on human experimentation, the Association 
claimed that the Declaration of Helsinki provided a more doctor-centered and 
“realistic” set of principles for human experimentation. The document was meant 
to address the problems with the restrictive nature of the code and the lack of 
adherence to the Code’s principles by the medical field.   (Schmidt, 2004, p. 282)  
Henry K. Beecher, a prominent anesthesiologist known for exposing unethical 
research conducted at the time, stated about the Declaration,  
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“The Nuremberg Code presents a rigid act of legalistic 
demands...The Declaration of Helsinki, on the other hand, presents 
a set of guides.  It is an ethical as opposed to a legalistic document 
and is thus a more broadly useful instrument than the one 
formulated at Nuremberg...Until recently the Western world was 
threatened with the imposition of the Nuremberg Code as a 
Western credo.  With the declaration of Helsinki, this danger is 
apparently now past” (Annas, 1992, p.205).  
 
This statement reflects the apparent “sigh of relief” issued by the medical 
community upon discovering that they would not be encouraged to conduct 
research under the stringent requirements of the Nuremberg Code.  Instead, the 
Declaration of Helsinki offered a more “lenient” set of principles for them to abide 
by.  
While the current director of the WMA does confirm that the Nuremberg 
Code was referenced in the creation of the Declaration of Helsinki, there are 
significant differences between the two documents. (Perley et al, 1992, p. 158) 
When introducing the Declaration, the World Medical Association stated that it 
had created the document, “Because it is essential that the results of laboratory 
experiments be applied to human beings to further scientific knowledge and to 
help suffering humanity” (Mariner, 1992, p. 289). Though the wording is subtle, a 
comparison of the two documents reveals that the differences in their content are 
explained primarily by the differences in their purpose. The Nuremberg Code was 
created in the aftermath of the exposure of heinous crimes in which medicine 
played a key role.  It aimed to address the experiments by creating regulations 
that would prevent the repetition of these events in the future.  The Declaration of 
Helsinki, however, was written “by physicians for physicians”.  (Mariner, 1992, p. 
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289).  The document, “Embodies a general faith in the methods and 
achievements of medical science and an acceptance of the premise that 
scientific success depends upon testing new substances in human subjects” 
(Mariner, p. 289).  
 Like the Nuremberg Code, the Declaration requires that proposed 
research be based on laboratory and animal experiments or other scientifically 
established facts. The documents both require that research be conducted by 
qualified persons and that the benefits of the research be measured against the 
risks to the subject.  Both give the subject freedom to withdraw from the 
experiment at any time and mandate that the experimenter immediately 
discontinue any experiment in which it becomes apparent the subject may be 
harmed.  (Perley et al. 1992, p. 158)  
 However, the Declaration of Helsinki omits many of the requirements 
made of doctors in the Nuremberg Code.  There are no prohibitions on the use of 
force, deceit or other forms of coercion to attract subjects. (Katz, 1992a, p. 232)  
In addition, the Declaration lifts the ban on the use of prisoners and mental health 
inmates in experiments.  (Schmidt, 2004, p. 283) The principle of informed 
consent included in the original Declaration of Helsinki is far less stringently 
worded than in the Nuremberg Code, and is not listed as one of the document’s 
basic principles (Perley et al., 1992, p. 158.) 
The Declaration of Helsinki has been revised a number of times since its 
original inception.  The most significant of these revisions occurred in 1975 and 
2000. The 1975 regulations created a document known as Helsinki II which is 
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recognized as “Providing the fundamental guiding principles for the conduct of 
biomedical research involving human subjects” (Perley et. al, 1992, p.159). The 
revisions repositioned the principle of informed consent in the first paragraphs of 
the document and greater emphasis was placed on responsibility to the 
individual.  (“Declaration of Helsinki”) In addition, it also included an ethical 
review committee, a passage that played a significant role in the creation of the 
IRB method in the United States. (Perley et. al, 1992, p. 159) 
 Together, the Nuremberg Code and Declaration of Helsinki constitute “the 
basis of universality in the field of ethical-moral standards in human 
experimentation” (Perley et. al, 1992, p. 160). Both documents make strong 
statements about the precautions that must be taken in order to ensure the 
protection of subject rights. However, the ways that they approach this are very 
different.  The Declaration of Helsinki reflects, “A more benign modern attitude 
toward biomedical research” and seems to accept that medical progress must 
ultimately depend on research on human subjects (Mariner, 1992, p. 289). 
However, this difference in attitude is important when considering the history of 
medical ethics as a whole.  In his book on the development of the Nuremberg 
Code, Ulf Schmidt writes,  
“In 1964 a crucial shift was initiated in the Helsinki Declaration about the quality 
of international medical ethics codes, from the rights of the patients and the 
protection of human subjects in experimental research to the protection of patient 
welfare through physicians’ responsibility.  It was a move away from the essential 
requirement of informed consent as stated in the Nuremberg Code, beginning a 
watering-down process of the Code that continues to this day” (2004, p. 283). 
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The shift in focus of ethical documents so soon after the release of the 
Nuremberg Code and the conclusion of the Nuremberg Trials outlines how 
quickly the world began to shift away from post-World War II philosophies.  Jay 
Katz wrote on this shift saying,  
“The Declaration of Helsinki was enacted in the shadow of the 
Holocaust experiments; yet, less than 20 years after the Nuremberg 
Code was promulgated, concerns over the advancement of science 
began to overshadow concerns over the integrity of the person” 
(Katz 1992a, p. 234). 
 
The aim of the Nuremberg Code was to create a set of principles that, if 
observed, would prevent the repetition of events like the Nazi experiments. 
Therefore, this shift in focus is significant. The shift in ideology has been 
accompanied by a shift in policy; it was the Declaration of Helsinki, and not the 
Nuremberg Code, that was adopted by the Food and Drug Administration when it 
issued its regulations governing experimental drug research. (Mariner, 1992, p. 
290)  
The purpose of emphasizing the significance of the shift from the 
Nuremberg Code to the Declaration of Helsinki is simply to provide a greater 
understanding and perspective of the ways that ethics has been created and 
developed in the United States during the second half of the twentieth century.  It 
is not to say that this shift in trajectory of medical ethics has either harmed or 
helped the field of medicine.  Instead, understanding the Nuremberg Code, the 
Declaration of Helsinki and the historical events surrounding both documents 
provides the tools needed for an informed analysis of one of the first United 
States Government issued documents on medical ethics, the Belmont Report. 
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This document that is now credited as the foundation of modern day IRB 
research and is the final document this chapter will examine. (Office for Human 
Research Protections [OHRP], 1993) 
The Belmont Report was released in 1978 by the National Commission for 
the Protection of Human Subjects of Biomedical and Behavioral Research. 
(“Belmont Report”) This Commission had been established in 1974 as a part of 
the National Research Act and was meant to formulate a new set of bioethical 
standards in the aftermath of the exposure of the Tuskegee experiments. 
(“National Research Act”) These experiments, also known as the USPHS 
Syphilis Study, took place in Macon County, Alabama, and involved the 
participation of 600 men, around half of whom entered the study already having 
contracted syphilis.  (Katz, 1992b, p. 246) The long term study aimed to compare 
those with the disease to the control group in order to determine the effects of the 
disease.  Though the cure for syphilis was discovered in the 1940s, the study 
was continued until 1972.  During this time, those in the study with the disease 
were deliberately left untreated.  Furthermore, the subjects were not told about 
their condition, nor what the experiment was attempting to learn from their 
participation. (“About the USPHS Syphilis Study”, 2015)   This lack of informed 
consent, as well as the blatant negligence of subject well-being by the 
researchers conducting the study are in violation of the Nuremberg Code and the 
Declaration of Helsinki.  The National Research Act, as well as the Commissions 
established as a result of it were seen by many as recognition by the American 
government that the ethical standards set forth by the Nuremberg Code, as well 
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as the Declaration of Helsinki, were not being observed by scientists in America 
and that further action must be taken in order to prevent future unethical 
research. (“About the USPHS Syphilis Study”, 2015)   
 The Belmont Report is fairly succinct.  Following the introduction, it lists 
three basic ethical principles (respect for persons, beneficence and justice) that 
should guide modern research .  It then identifies three areas of application for 
these principles: informed consent, assessments of risks and benefits, and 
selection of subjects as the main concerns of ethics in human research.  
(Belmont Report).  The Belmont Report serves as the document of reference for 
the modern day IRB Guidelines. (OHRP, 1993) Notably, the Belmont Report is 
significantly shorter than both the Nuremberg Code and the Declaration of 
Helsinki.  This was done deliberately by the Commission following an agreement 
that the other codes were “lists of regulations that may not allow the resolution of 
complex ethical questions” (Fischer, 2006, p.72).  The Belmont Report gives far 
less specific and stringent guidelines in an attempt to allow for greater 
recognition of the “fundamental principles” of medical ethics.  It was believed 
that, “Researchers could then appeal to these principles to resolve dilemmas for 
which other codes have no answer” (Fischer, 2006, p. 72).  
The Belmont Report represents a further shift in the world of medical 
ethics towards providing researchers with tools to address medical issues 
instead of simply placing requirements and limitations on their experiments in the 
way that the Nuremberg Code did.  Historically, this makes sense-the second 
half of the twentieth century saw a rapid rise in medical discovery and these new 
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technologies and processes were in large part a result of biomedical research.  
Therefore, at the same time that the actions of the Nazi doctors were becoming a 
distant pre-Cold War memory, the field of medical technology and research was 
rapidly expanding. As a result of this many researchers were finding themselves 
in ethical situations not covered by the either the Nuremberg Code or the 
Declaration of Helsinki. The Belmont Report aims to address this by removing 
specific guidelines and instead providing researchers with a more general 
summary of what the commission believed to be the most essential elements of 
ethics in research.  The Report becomes more of a tool to be utilized by 
researchers when making ethical decisions rather than a document attempting to 
govern their research.  This continues the trend in ethical literature (begun by the 
shift from Nuremberg to Helsinki) of returning the responsibility for patient safety 
and research ethics to the researcher.  It is for this reason that the returned 
emphasis of the importance of informed consent in the Belmont Report is so 
important.   
 
Informed Consent: 
The following section of this chapter pays particular attention to the 
concept of informed consent and the role it plays in the ethical justification of 
biomedical research as a whole.  As it has already been discussed, conducting 
research on humans, especially the types of research in which the subject can 
gain nothing from their participation, provides several obstacles to the world of 
ethics.  However, despite these problems the importance of bioethical research 
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to the world of medicine and medical technology is acknowledged by most 
ethicists. In addition, past events such as the atrocities of Nazi German 
experiments and the Tuskegee experiments are evidence that research is an 
area in great need of constant and persistent ethical influence and scrutiny.  It is 
for this reason that I now present the ways in which ethicists are able to justify 
some types of biomedical research in their terminology.   
The first principle of the Nuremberg Code begins, “The voluntary consent 
of the human subject is absolutely essential” (HHS site, Nuremberg). The 
document goes on to define informed consent saying,  
“The person involved should have legal capacity to give consent; 
should be so situated as to be able to exercise free power of 
choice, without the intervention of any element of force, fraud, 
deceit, duress, over-reaching, or other ulterior form of constraint or 
coercion; and should have sufficient knowledge and 
comprehension of the elements of the subject matter involved, as to 
enable him to make an understanding and enlightened decision. 
This latter element requires that, before the acceptance of an 
affirmative decision by the experimental subject, there should be 
made known to him the nature, duration, and purpose of the 
experiment; the method and means by which it is to be conducted; 
all inconveniences and hazards reasonably to be expected; and the 
effects upon his health or person, which may possibly come from 
his participation in the experiment. 
The duty and responsibility for ascertaining the quality of the 
consent rests upon each individual who initiates, directs or engages 
in the experiment. It is a personal duty and responsibility which may 
not be delegated to another with impunity.” (Nuremberg Code).  
 
The significance of this first principle comes from the priority it places in the 
autonomous rights of the individual over the interests of science and society.  
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(Grodin, 1992, p. 277)   The actions of Nazi doctors during World War II forced 
the world to reexamine where medicine places the values of the individual and 
society in the area of biomedical research.  In his book on this time period, NYU 
bioethicist Arthur Caplan writes,  
“The torture and killing that were at the core of Nazi medical 
experiments involves not only murder but also the exploitation of 
human beings to serve the goals of science.  The evil inherent in 
Nazi medical experimentation was not simply that people suffered 
and died but that they were exploited for science and medicine as 
they died” (1992b, p. 65).  
 
The Nazi experiments revealed a moral and ethical fallibility in the world of 
medicine that had previously been thought to be addressed by the professional 
interests of doctors to the science of healing. Early in the 20th century it began to 
be apparent that the advent of biomedical research required doctors to be 
simultaneously physicians and scientists.  This created ethical problems for 
researchers not previously encountered in the world of medicine. This occurred 
simultaneously with the increased recognition that science was not an 
independent body, but instead a field heavily influenced by the social and political 
situations it existed within. The actions of German doctors during World War II 
provide a ready example of the potential for the politicization of science.  Robert 
Proctor writes, “It used to be argued (by both logical positivists and many liberal 
sociologists) that science is either inherently democratic or, at worst, apolitical, 
and that the politicizations of science implies its destruction” (Proctor, 1992a, p. 
17). The ways the doctors both assisted and utilized the Nazi regime for their 
individual and scientific interests made this view unsustainable. 
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 Subsequent events have shown that even in situations less extreme than 
those in Nazi Germany, biomedical research inherently raises tensions between 
the values of the freedom of scientific inquiry and the protection of individual 
inviolability. (Katz, 1992b, p. 234)  Following World War II, it was decided that if 
biomedical research were to continue, action must be taken to protect the rights 
of the individual. Though the entirety of the Nuremberg Code aims to address 
this, it is the principle of informed consent that has received the most recognition 
as a key component of ethical research.  The consent principle of the Code has 
the status of an absolute, a priori principle. (Schmidt, 2004, p. 5)  Consent, 
according to the code, is non-negotiable. (Caplan, 1992a, p. 269) 
 The principle of informed consent is essential to the existence of 
biomedical research.  The principle directly addresses the concept of “humanity”, 
a word which, in the world of ethics, is defined as “a measurement of the moral 
progress of society based on the ways that the society recognizes and respects 
the integrity, autonomy and intrinsic worth of human beings as expressed by the 
laws and customs of that society”. (Macklin,1992, p. 242)  Therefore, by 
preserving integrity and autonomy, we can continue biomedical research without 
sacrificing the “humanity” of current society.  Autonomous action has been 
defined as action by “normal choosers” (those mentally capacitated to make 
decisions for themselves) who act “intentionally, with understanding, and without 
controlling influences that determine their action” (Pedroni & Pimple, 2001, p. 2).  
The principle of informed consent provides an ethically viable possibility for 
continued human experimentation by letting the research subject make informed 
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decisions about their role and therefore preserving the subject’s autonomy and 
integrity.  Jon Vegar Hugaas outlines the necessity of informed consent saying, 
“The two principles of respect for autonomy and integrity and the principle of 
informed consent form a triangle in biomedical ethics, in such a way that if we 
accept one of them, we accept them all, and therefore we cannot turn down one 
without turning down the others as well” (2002,p. 68).   Arthur Caplan describes 
informed consent as “a counter to utilitarianism”, explaining that the principle 
responds to ethical questions surrounding the role of human subjects in research 
should be by allowing them to choose. (personal communication, December 10, 
2014)  
 Since the creation of the Nuremberg code, the notion of informed consent 
has for some become the “sine qua non” for human experimentation. (Perley et 
al., 1992, p.155).  The Code provides the “most complete and authoritative 
statement of the law of informed consent” and is “part of international common 
law” (Annas, 1992, p. 201). Since that time, informed consent has been 
preserved in documents of ethical standards.  However, while it has remained a 
consistent ethical guideline, lack of adherence to this principle by the medical 
community has led to several instances of unethical research.  Examples of this 
are apparent in events such as the Tuskegee experiments. In addition, the fight 
for recognition of the importance of informed consent has met resistance from a 
government standpoint as well.  In 1966 the FDA, recognizing the failure of the 
biomedical industry in obtaining these forms of patient consent promulgated 
patient consent regulations to the biomedical industry. (Glantz, 1992 ,p.186) 
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However, in 1990, the FDA also granted the Department of Defense a waiver for 
the informed consent requirements so that they could experiment with  
unapproved drugs and vaccines on soldiers as part of project Desert Storm. 
(Neuhaus, 1992, p. 216). Throughout the second half of the 20th century, other 
occurrences, such as LSD experiments conducted on soldiers without their 
knowledge in Manhattan, as well as countless other examples also serve as 
examples of the lack of priority given to informed consent.  (Katz, 1992a, p. 231) 
Informed consent is difficult. On the one hand, it provides an ethically 
viable way to protect the rights of the individual by preserving that person’s 
autonomy and integrity.  It places the concerns for a subject’s welfare over the 
interests of science and society.  (Grodin, 1992, p. 277) However, it is also time 
consuming, it can limit the subject pool, and it means extra paperwork. The 
concept is also very relative. The levels to which a subject must understand an 
experiment in order to make an informed decision about it are difficult to define.  
When looked at from an ethical standpoint, the principle of informed consent 
seems essential.  However, in the highly competitive, fast-paced environment 
that many researchers find themselves in today, the responsibility of the scientist 
to the patient may pale against pressures they experience from outside forces to 
produce results from their experiments. Therefore, with the the recognition that 
there has been a shift towards returning the power of discretion to the physician 
(as a result of the Belmont Report) as well as a history of neglect of the principles 
of informed consent, modern day IRB processes have been developed to attempt 
to absolve the researcher from at least a part of the responsibility and therefore 
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mediate some of the unfortunate tension between rights of the individual and 
interests of society that is so inherent in biomedical research. 
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Current IRB Policies 
 
“When the fences and the safety rails have been removed, when the signposts 
have been changed or taken down, what reason is there to believe that people in 
our time will not do what was done then?”  
-Richard Neuhaus, “The Way They Were, The Way We Are” 
 
 In 1989, it was agreed that all federally connected research in the United 
States should come under the purview of a single set of regulations.  In 1991, the 
Department of Health and Human Services (DHHS) published Title 45: Public 
Welfare, Part 46: Protection of Human Subjects. Subpart A of this represents the 
basic policy for protection of human research subjects.  This law became known 
as the “Common Rule”,  with 16 federal agencies agreeing to operate under its 
regulations. (Fischer, 2006, p. 73) The Common Rule applies to any research 
done that is supported by or subject to oversight by any of the 16 government 
agencies involved. (Ex. private pharmaceutical research overseen by the FDA) 
The Common Rule, is based in large part on the Belmont Report. It created and 
set guidelines for an Institutional Review Board (IRB).  IRBs are given the 
responsibility of evaluating “the risk/benefit ratio of proposals, selection of 
subjects, and protection of subjects’ confidentiality” as well as insuring that 
“potential subjects will be informed about the research prior to their consent 
being sought and that the consent is documented”. (Fischer, 2006, p.74) The 
breaches of medical ethics in the 20th century were seen by some as proof that 
researchers could not be trusted to make ethical decisions because of their 
investment in their own research. IRBs were developed with the hope that, 
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“Groups of scientists deliberating together could make better judgments than 
individuals in lone reflection” (Stark, 2012, p. 109). 
 The Code of Federal Regulations (CFR) defines an IRB as, “Any board, 
committee, or other group formally designated by an institution to review, to 
approve the initiation of, and to conduct periodic review of, biomedical research 
involving human subjects” (IRB:General Provisions § 56.101, 2014). The CFR 
outlines the structure of an IRB. It states that an IRB should be composed of at 
least five members who possess different backgrounds so as to “promote 
complete and adequate review of research activities.”  (Protection of Human 
Subjects § 46.107, 2009)  The document requires that an Institutional Review 
Board be “Sufficiently qualified through the experience and expertise of its 
members, and the diversity of the members, including consideration of race, 
gender, and cultural backgrounds and sensitivity to such issues as community 
attitudes” (Protection of Human Subjects § 46.107, 2009)  Given these 
components, the document asserts that an IRB will therefore be able to provide 
advice and counsel in “safeguarding the rights and welfare of human subjects” as 
well as be able to “ascertain the acceptability of proposed research in terms of 
institutional commitments and regulations, applicable law, and standards of 
professional conduct and practice” (Protection of Human Subjects § 46.107, 
2009).  The document requires each IRB to contain at least one person whose 
primary concerns are scientific, and one whose primary concerns are 
nonscientific.  (PHS § 46.107, 2009)  
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 The CFR describes the role of the IRB as something of a “watchdog” for 
the research conducted at the institution.  It is the role of the IRB to perform initial 
and continuing review of research, as well as review and approve any changes to 
research that may occur during experimentation.  IRBs are required to conduct 
regular inquiries into the research process based on the risk level of the research 
and ensure that ethical protocols are being observed. In addition, the IRBs are 
responsible for documentation of research and for reporting “unanticipated 
problems involving risks to human subjects and any instance of serious or 
continuing noncompliance with these regulations or the requirements or 
determinations of the IRB and subsequent suspension and termination of IRB 
approval to institutional officials and the FDA”  (IRB:IRB Functions § 56.108, 
2014). In essence, the intended role of the IRB is to oversee research and 
provide physicians with both a guiding force and a watchful eye. 
 IRBs are technically run by the institution that sponsors the experiments 
they review, however, they are subject to government oversight. The Code of 
Federal Regulations lists the FDA as the primary source of this oversight.  Just 
as IRBs are required to oversee research, the institution is required to oversee 
the IRB and the FDA is required to ensure the correct operation of the institution.  
However, the FDA does this by conducting reviews of the conduct of the IRBs 
themselves.  Any identification of a lack of adherence to the CFR by an IRB 
results in negative action against the institution as well as the IRB itself.  
Disciplinary actions by the FDA include withholding approval for any new studies, 
termination of ongoing studies, retracting the ability to recruit new subjects to a 
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particular study and the notification of relevant state and federal regulatory 
agencies to the indiscretions of the institution and the institution’s IRB. (IRB: 
Administrative Actions §56.120, 2014)  In addition, institutions can have funding 
revoked and possibly face clinical penalties.  (Glantz, 1992, p. 189) This 
oversight as well as the potential consequences of failing to adhere to protocols 
is meant to motivate institutions to create and maintain responsible and effective 
IRBs.  In turn, the presence of the IRB and the requirements for funding are 
intended to encourage researchers develop ethical protocols from the beginning.   
 Institutional Review Boards are given a comparatively large degree of 
freedom in the decisions that they make regarding the approval of biomedical 
experiments.  However, the Code of Federal Regulations does list a series of 
requirements that experiments must meet to qualify for approval.  A study must 
use procedures “consistent with sound research design and which do not 
unnecessarily expose subjects to risk”(IRB:IRB Functions §56.110, 2014).  Risks 
to subjects must be “reasonable in relation to anticipated benefits”(IRB:IRB 
Functions § 56.110, 2014).  In determining this, IRBs should not consider the 
long-range effects of the knowledge gained in the research, only assessing risks 
or benefits that may directly result from the research.  IRBs are in charge of 
ensuring that the selection of subjects is equitable and that a particular vigilance 
is maintained for any research associated with “vulnerable populations” (children, 
prisoners, pregnant women, handicapped, mentally disabled or economically 
and/or educationally disadvantaged persons). One of the ways they are charged 
with doing this is through informed consent.   
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 The Code of Federal Regulations states that an IRB must request and 
review proof of informed consent from subjects from every relevant experiment 
and must continue to monitor these experiments in order to ensure that the 
guidelines set are being followed.  The CFR’s definition of informed consent 
retains the definition originally expressed by the Nuremberg Code.  The 
document maintains the rights of the subject to withdraw from a study at any 
time. (Glantz, 1992, p.189) However, unlike the Nuremberg Code, or any other 
previous documents of medical ethics, the CFR gives an IRB the power to waive 
the requirement for informed consent given that the board determines the 
experiment will have sufficient oversight similar to that provided by an IRB, or 
that the research could not be performed without a waiver. (Protection of Human 
Subjects § 46.116, 2009)  This responsibility to assess the necessity of informed 
consent, as well as monitoring the procedures for obtaining it deviates from 
previous guidelines by removing the responsibility from the researcher and 
instead placing it on the Institutional Review Board.  In theory, this transfer of 
responsibility to a larger group would decrease the likelihood of unethical 
research.  Once again, we see the idea that groups of scientists make better 
decisions than the individual alone.  
 In addition to the doctrine and definition of informed consent in the main 
document of the CFR, there are also two separate sections that aim to directly 
address policies regarding the rights of children and prisoners in biomedical 
research. These two populations are mentioned specifically because past events 
have shown these populations to be especially at risk of being taken advantage 
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of in research.  This additional protection aims to address problems identified in 
these populations with informed consent and the ability of the these subjects to 
make truly autonomous decisions. 
 In section 46.401 of the document, research on children is divided into 4 
classes:  research not involving greater than minimal risk, research involving 
greater than minimal risk but presenting the prospect of direct benefit to the 
subject, research involving greater than minimal risk and no prospect of direct 
benefit to the subject but likely to yield generalizable knowledge about the 
subject’s disorder or condition, and research not otherwise approvable which 
presents an opportunity to understand, prevent or alleviate a serious problem 
affecting the health or welfare of children (2009).  An IRB is responsible for 
assessing the risk a particular experiment poses to its subjects and then 
classifying it into one of these categories.  Each category receives slightly 
different treatment by the IRB, including variations in amount of documentation 
and frequency of oversight.  Any experiments falling in the fourth category 
(research not otherwise approvable) requires the approval of the Secretary of the 
Department of Human Health Services (DHHS) before it can proceed.  (PHS: 
Additional Protections for Children §46.401, 2009) 
 Similarly, the Code of Federal Regulations places additional requirements 
on research done on prisoners in order to ensure the protection of the rights of 
those individuals.  Prison research, like research on children, is classified as one 
of four categories: studies of possible causes, effects, or processes of 
incarceration and of criminal behavior, studies of prisons as institutions or of 
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prisoners as incarcerated persons, research on conditions particularly affecting 
prisoners as a class and research on innovative and accepted practices that 
have the “intent and reasonable probability” of improving the health or well-being 
of the subject.  (PHS:Addition Protections...Involving Prisoners §46.301, 2009) 
The third of these categories, research on conditions particularly affecting 
prisoners must be approved by the Secretary of the DHHS.  The prisoner 
regulations found in the CFR are even more stringent than those in the 
Nuremberg Code. They require that there be a compelling reason for using 
prisoners, as opposed to a more general population.  The document states the 
reasoning behind the strictness of these regulations saying, 
 “Inasmuch as prisoners may be under constraints because of their 
incarceration which could affect their ability to make a truly voluntary and un-
coerced decision whether or not to participate as subject in research, it is the 
purpose of this subpart to provide additional safeguards for the protections 
of prisoners involved in activities to which this subpart is applicable” 
(PHS:Addition Protections...Involving Prisoners §46.302, 2009) 
 
IRBs reviewing prisoner research are structured differently than a normal IRB.  In 
IRBs concerned with prisoner research, the regulations state that one member of 
the IRB, “Shall be a prisoner, or a prisoner representative with appropriate 
background and experience to serve in that capacity, except that where a 
particular research project is reviewed by more than one Board only one Board 
need satisfy this requirement” ( §46.302, 2009). This requirement along with the 
others made in the document aim to create additional regulations to protect the 
rights of vulnerable groups.   
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 When analyzing the implications of each change in the regulations and 
procedures made by the Code of Federal Regulations, the main considerations is 
how effective the IRB system is in identifying and addressing ethical problems 
posed to modern medical research.  There are both positive and negative 
aspects to the IRB system. On the one hand, IRBs are able to serve as 
watchdogs, ensuring that researchers are observing ethical research practices by 
assessing the risks of experiments and monitoring research to ensure adherence 
to protocols. IRBs place responsibility for the protection of human subjects on the 
institution, rather than the investigator conducting the research. (Glantz, 1992, 
p.189)  IRBs are also a far more decentralized system of ethical review than had 
been previously used in the medical research. Certainly, they ensure that 
researchers are observing the CFR.  However, they are also given a great 
amount of leeway in the decisions they make regarding the specifics of research 
protocol and oversight.  Theoretically this gives IRBs a greater ability to tackle 
some of the nuanced and difficult problems that may arise in creating and 
maintaining ethical research.  However,  the lack of rigidity in the design of the 
system also raises questions as to the proper role of each component of an 
Institutional Review Board and creates a lack of uniformity in the decisions made 
by each IRB. IRBs are frequently tasked to make many decisions by interpreting 
and inferring ethical practices using the CFR. This can be tricky as well as 
subjective. Factors such as past experiences of the individuals comprising an 
IRB or personal knowledge of a researcher by members of an IRB have been 
observed to influence the board’s decisions. 
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One such example of this can be seen in the ways that community 
members act within an IRB. The inclusion of community members in IRBs is 
meant to provide an outside perspective on the research, one whose primary 
concern is not science or scientific progress.  In addition, community members 
can assist in helping the IRB be sensitive to community attitudes when 
considering and approving research proposals. In her observations of the 
processes involved in IRB decision making, Laura Stark, a sociologist who 
researched the origin of the IRB, observed that community members, “Keep the 
scientists and the medical folks honest because their perspective is not to drive 
or improve the science” (2012, p. 24).  However, the ways that IRBs include and 
interact with their community members varies. Often, community members were 
formally involved in the medical or scientific fields and therefore may have trouble 
representing a layperson on the IRB.  (Klitzman, 2012)  Community members 
often struggle with the ability to accurately represent community attitudes in full.  
Because community members aren’t associated with the scientific community, 
IRBs struggle with the level that they are required to engage and include them 
and how thoroughly to explain complicated medical terminology and procedures.  
(Klitzman, 2012) 
 When considering how effective the IRB format is in ensuring ethical 
research, Arthur Caplan,  pointed out both positive and negative aspects of the 
system.  He named the IRB as the “Protector of the doctrine of informed 
consent”, saying, “[IRBs] help because they explain to the researcher that you 
have a motive to do this--the more that subjects understand, the less likely that 
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they are to be noncompliant with the research protocol… So there’s the idea if 
[the researchers] don’t buy into the model, then you don’t get great science out” 
(personal communication, December 10, 2014).  Caplan argues that IRBs are 
beneficial because of their ability to inquire into the “soundness of the 
methodology or the reliability of the hypothesis and experimental design of a 
certain project”. (personal communication, December 10, 2014) They are in a 
position which allows them to question researchers and experiments with a 
legitimacy that researchers respect.  In addition, it is to the advantage of a 
researcher to observe the decisions made by an IRB. Caplan states, “If you get 
an adverse event, its much better to have the IRB processes documented…It will 
help you, as a researcher, to survive any outcome thats not predictable or not 
due to any maleficence” (personal communication, December 10, 2014).  This is 
important as many of the problems that were seen with the Nuremberg code and 
the Declaration of Helsinki stemmed from the lack of respect granted to them by 
researchers and the inability to enforce any of the guidelines they outlines.   
While they may exert a greater degree of influence than previous ethical 
policies, IRBs present additional problems in the lack of uniformity in their 
decisions.   Laura Stark writes, “The point of the rules is to enable civil servants 
to make rote, seemingly impersonal decisions in our stead.  In theory, the rules 
are so precise that they would allow all qualified people to reach the same 
conclusion.  Administrative laws are designed to make human decisions appear 
to be objective and beyond the judgment of a given individual” (2012, p. 3). 
However, Stark also observed, “The issue of who gets authorized to sit around 
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the table has a remarkable effect on the decision making process” (2012, p. 37) 
IRBs, and the decisions they make, are so detailed and nuanced that they rarely 
result in a uniformity.  As Gernot Bohme, a German philosopher of science, 
points out in his essay on unethical medical research, “Universalistic principles, 
precisely because they are meant to be valid irrespective of culture, religion, and 
class-identity, can lead only to the most minimalist form of ethics” (2007, p. 27). 
Therefore, in order to make the detailed decisions, Institutional Review Boards 
often draw upon many different influences in the decision making process.  Stark 
writes, “The people whom board members called to mind when they imagined a 
research subject-a relative or a student, for example-reinforced the race, class, 
and gender biases of the board membership” (2012, p. 14).  
 Though this variance in the decisions made has always been a topic of 
issue for ethicists, the issue has recently been brought to the forefront by the 
expansion of multisite and multinational experiments.  Arthur Caplan stated, “Part 
of the local IRB notion was to have me watch you or you watch be…it could be a 
kind of local police force.  You know, single investigator, working down the hall.  
Well, now its a thousand investigators working around the world..I’m not watching 
anyone I know and I can’t monitor anything that closely” (Personal 
Communication, December 10, 2014).  Today many experiments are worldwide, 
taking place at multiple sites, with each site having its own IRB and review 
process.  Though trials are usually run using the same protocol at each site, the 
decisions made by that site’s IRB may vary.  This is often the case in the ways 
they approve consent forms and research practices. (Check et al., 2013, p. 561) 
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Researchers must then take additional time to address the issues raised by each 
IRB in order to create a unified experiment.  This can result in extensive changes 
to consent forms as a result of opposing requests by multiple IRBs, making the 
documents longer, more complex, and often introducing errors. (Check et al., 
2013, p. 563)  This can delay participant enrollment and delay start up. (Check et 
al., 2013, p.560) In a study done on  a multi-center therapeutic West Nile virus 
trial, waiting for multiple local IRB approvals contributed to major delays in sites’ 
ability to begin enrollment (Check et al., 2013, p.563).  This process results in 
frequent frustrations from researchers who are under pressure to produce timely 
results. The issue of multisite IRBs is important because it provides one example 
of the inability of the IRB system to handle recent changes in the biomedical 
experimental process.  Other problems, such as lack of resources need to 
properly review research protocols and lack of scientific understanding by IRB 
members of technologies and methods used in the experiments have also been 
observed. (Caplan, personal communication, December 10, 2014) 
 The Code of Federal Regulations and the IRBs that result from it do 
address some of the problems observed with previous ethical documents like the 
Nuremberg Code and the Declaration of Helsinki.  As Laura Stark points out, 
IRBs are, in theory, guided by a respect for persons, beneficence and justice in 
their interpretations of the Code of Federal Regulations. (2012, p.11) Their 
inclusion of community members ideally provides non-scientific voices and the 
power given to it by the Federal Government helps avoid any problems of 
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disobedience or apathy by researchers.  However, the format is certainly not 
perfect.  
 IRBs are given the flexibility necessary to respond to a myriad of ethical 
issues, however, as a result of this decision making ability, the results are 
unpredictable.  This unpredictability causes its own set of issues, some which are 
becoming more and more prominent as the face of research continues to shift 
globally.  As biomedical research progresses there has been an increase in the 
observed limitations of the IRB process.   
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IRBs and the Modern Research Environment  
 
“Solutions, pedagogical and structural, for the challenges of 
research integrity need to be customized to the variability of climate 
at the subunit level” 
-Organization Research Climates Survey   
 
The development of the IRB process is deeply rooted in the global history of 
bioethics, stemming in large part from the Nuremberg Code and the actions of 
the Nazi doctors.  The regulations contained in the CFR attempt to address past 
violations of the principle of bioethics.  This is especially apparent in the 
emphasis the regulations place on informed consent and the extra protections it 
provides to vulnerable groups such as children and prisoners.  However, while it 
does address past actions and problems in bioethics, whether the IRB process 
effectively addresses current research conditions and dilemmas is still a matter of 
concern. The justification for the IRB process centers on the idea that a group of 
physicians is better able to make ethical decisions than the individuals.  
However, the question is, does this shift actually promote more ethical research?  
In this chapter I present several problems that have begun to emerge as a result 
of the modern research environment and the IRB system’s inability to address 
these issues both as a result of its status as a reactionary document and of its 
inability to address the root causes of unethical behavior.  
 One of the most important things to consider when examining the changes 
is that biomedical research in the United States has rapidly expanded in the 
twenty first century.  (“Biomedical Research”)  Funding for research both from the 
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National Institute of Health (Government Funding) and from pharmaceutical 
companies, has been increasing in the past thirty years.  Today, industry 
sponsored research accounts for sixty percent of funding.  This increase in 
funding has been met by an explosion of research centers and influx of 
researchers to the profession. This has led to greater pressure on researchers to 
get things done in the quickest, most efficient manner.  In 2012, the NIH began 
publishing “Success Rates”, a statistic measuring the results published per dollar 
spent by the Institute.  Industry funded research also pushes heavily for results.   
According to Arthur Caplan, industry grants are, “More outcomes oriented 
and speed oriented than a foundation or government grant-they have a timeline, 
they paid you the money and they want an answer…They don’t even necessarily 
want favorable results, they just want results” (Personal Communication, 
December 10, 2014).  Caplan also explained that there is additional pressure 
from medical schools to produce “headlines” and compete with other institutions. 
(Personal Communication, December 10, 2014) Coupled with a decreased 
availability of jobs, the culture of biomedical research has been described as 
“publish or perish”.  (Schmidt, 2004, p. 285)  Other individuals in the world of 
bioethics have raised similar concerns about the current research environment.  
Historian Ulf Schmidt claims that the increase in pressure on researchers to 
produce has led to a “culture of shortcuts” that can manifest itself in neglect of 
policies such as informed consent and equal recruitment of subjects.  (Schmidt, 
2004, p. 285) In her essay on the sources of unethical research, author and 
physician Marcia Angell stated, “It stems from the desire to obtain unambiguous 
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answers to scientific questions as rapidly as possible in a highly competitive 
research environment” (1992, p.279).  
Unfortunately, recent studies have corroborated these theories. A study 
done in Belgium in 2012 found that “Excessive pressure to publish scientific 
articles contributes to scientific misconduct, at least among European medical 
scientists” (Tijdink, Verbeke, Smulders, 2014, p. 68). In a study done by 
scientists Koocher and Keith-Spiegel it was found that 84% of researchers 
reported questionable behavior among colleagues.  (2010, p. 438) Another 2011 
study reported that 33% of the researchers surveyed self reported “questionable 
research practices”(DuBois, Anderson, Chibnall, 2013, p. 209).  One study 
showed that 4.9% of biomedical early career scientists reported modifying 
research results and 81% said they would be willing to fabricate data to win 
grants or be published. (Kalichman & Friedman, 1992) 
 As discussed in the previous chapter, the IRB structure was created with 
the idea that groups of researchers are better able to make ethical decisions than 
the individual alone.  The idea was to remove some of the great weight of 
responsibility from the researcher and instead place it on a collective body, one 
that is theoretically better able to monitor the research.  However, one 
unfortunate side effect of this process is that it places the researcher outside the 
realm of ethical decision making.  While the CFR still does include sections on 
informed consent and other principles that have historically been shown to be 
essential in medical ethics, because of the structure of the system these issues 
become the responsibility of the Institutional Review Board to protect and not the 
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researcher.  In an article published in the Journal of Academic Ethics in 2008, 
researcher Gary Allen argues, “A schism has emerged between the actual ethical 
conduct in research and the mechanism of following the rules” (p. 107).  The 
results of this schism have been observed in the work place.  A 2007 study of 
3,000 NIH-funded scientists found high levels of “normative dissonance” and 
suggested that the environments that scientists work in often do not reflect their 
own beliefs and values (Anderson, Martinson, & De Vries, 2005).   
 This level of normative dissonance and the separation of scientists from 
the ethics process is especially important given that the intense research 
environment often places scientists in a position in which their ability to efficiently 
and expediently get their experiments through the IRB process is advantageous 
both to the institution they work for and to their own careers. In addition, as a 
result of recent trends of institution wide shutdown of research following 
government identification of unethical conduct, institutions have begun to 
increase the pressure they place on IRBs to ensure complete compliance with 
federal regulations.   The system places the researchers and the IRBs in 
opposition to each other, with the IRB responsible for ensuring research 
compliance so as not to threaten the entire institution and the researchers 
focused on “getting past” the IRB to produce results for their funders.  Gary Allen 
writes, “Within these constraints, any reflection on the role or operation of ethics 
committees tends to be almost exclusively focused upon the goal of ensuring 
compliance, and compliance tends to be understood in terms of a researcher 
completing an application form for review by an ethics committee”  (2008, p. 
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107).  A 2004 paper by scientists Loff and Black observed that the functioning of 
ethics committees may actually encourage an abrogation of the responsibility of 
researchers to reflect upon the ethical issues associated with their own research 
(Loff & Black, 2004).   
As a result of this situation, researchers may be more prone to 
misrepresent their experiments in a way that will allow them to more expediently 
pass the IRB process.   As discussed previously, the IRB process can often 
delay research, especially in the case of multi-site trials. This can be a large 
source of frustration for researchers already under pressure to produce quickly 
and at low cost. Allen states, “There are indications that research designs are 
being compromised or ‘disfigured’ by existing ethical review processes, or that 
researchers may actually be presenting a distorted description of their research 
to get it past an ethics committee” (2008, p. 109). One study found that “A 
researcher who feels that a study protocol was unfairly reviewed by an IRB is 
more likely to find ways to bypass the IRB when conducting future research.  
(Dubois et. al, 2012, pg 10)  
This analysis of the current research environment and the rate of unethical 
research is concerning.  However, it is because of the identification of these 
problems that a historical understanding of the development of the IRB process 
as well as the significance of its principles becomes even more important.  Past 
ethical transgressions reveal the consequences of failing to place appropriate 
emphasis on medical ethics.  However, they also show that enforcing ethical 
principles through institutional or government oversight is limited and ultimately 
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useless if not done in a way that is conducive to the research environment. The 
Nazi experiments occurred despite ethics research, the Tuskegee experiments 
despite codes of ethics created by doctors, themselves.  Now, even despite 
increased oversight and the creation of IRBs, research has shown that unethical 
research still exists and growing pressure on researchers increases the likelihood 
of it continuing in the future.  
One possible reason for the failings of the IRB system is that the 
regulations put in place fail to accurately address where ethics stems from.  
Recent research looking at ethical decision making in the laboratory states that 
researchers gain most of their ethical guidance from looking at past experience, 
examples given to them by peers, and the training they received when beginning 
their careers.  One study found that exposure of first year doctoral students 
regularly exposed to unethical events were, “More likely to report having behaved 
unethically, to have lost ethical principles, and to feel guilty” (Mumford et al., 
2009, p.352).  It was found the such exposure provided “negative case models” 
from which the students would draw on later in their careers when dealing with 
similar situations.  The study suggests that the issue is not that graduate 
students are taught unethical principles through exposure to these events but 
rather, that these instances teach unethical work practices.  The authors state,  
“These findings suggest that exposure to unethical events led people to 
incorporate these events into their body of knowledge about how work is 
conducted.  This knowledge is, in turn, used as people make decisions about 
how to conduct their work, with exposure to unethical events giving rise to 
unethical decisions” (Mumford et al., 2009, p. 357). 
 
 54 
Research also suggests this is especially true for younger, less experienced, 
graduate students and those in charge of them (e.g. preceptors, mentors). 
Reviews of U.S. Office of Research Integrity cases of misconduct showed a 
positive correlation between research misconduct and poor mentoring by 
mentors and senior colleagues (Wright, Titus & Cornelison, 2008).   
 Studies have also shown that the perceptions researchers have of their 
research environment play a significant role in guiding their decisions.  In a study 
done on the effects of climate and environmental conditions on research integrity, 
it was found that competition, production pressure and poor study design were 
the most commonly seen causes for breaches in ethics.  (Mumford et al., 2007, 
p. 341).  The study findings suggested that young graduate students were 
especially prone to take actions (even unethical ones) when rewards and 
reinforcements were not readily available in the work environment.  Furthermore, 
it was hypothesized that doctoral students entering an environment they 
perceived as being committed to the work were more likely to make ethical 
decisions, while placing undue competitive pressure lead to more frequent 
unethical decision making across a number of domains. The researchers 
concluded that their findings suggest,  “Ethical decision making might be 
improved if people are not placed under excessive or undue pressure in the early 
phases of their career...Excessive competitive pressure may lead to the 
acquisition of beliefs likely to engender the potential for unethical decisions 
throughout an individual’s career” (Mumford et. al, 2007, p. 362).  
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This research is concerning for several reasons.  The previous evidence that that 
competitive pressures increase the likelihood of unethical decision making make 
the recent increase in research pressures more significant.  Secondly, evidence 
that researchers gather most of their guidance in ethical decision making from 
their peers and mentors means that the IRB oversight process, a system that is 
already struggling with its relationship to investigators and researchers, can have 
little benefit in encouraging ethical decision. Instead, the system places additional 
pressure and oversight on research, further alienating the two from each other.  
All of these factors are manifested in the apparent willingness of younger 
researchers to make unethical decisions in order to achieve career boosts. 
Given this evidence, the current system seems less than ideal.  However, if used 
correctly, the results of these studies as well as the records of frequent unethical 
research can be used to help guide further revision in the system.  Currently, it 
would seem that the system creates something of a self-perpetuating unethical 
research climate: pressure increases the likelihood of unethical decisions, 
unethical decisions tend to beget more unethical decisions, and observation of 
these decisions and climates by younger students drives them to make similar 
decisions in the future.  However, if appropriate action is taken the research 
gives the potential for a change in the way we do things through the reduction of 
pressure on researchers and the fostering of a more ethical research 
environment.  Doing this requires examining our system in order to figure out 
specifically who and where it is currently failing.  
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The Belmont Report and the IRB process represents America’s current response 
to addressing the tensions between biomedical research and bioethics.  The 
system reflects the many bouts of trial and error that have occurred in the last 
one hundred years between these two sectors.  The rules and processes 
involved are still changing, as ethics struggles to keep up with and reflect the 
modern research environment.  This is understandable; both of these fields are 
relatively modern and rapidly progressing.  It is apparent from recent studies and 
research that this system too, will need to be altered if not completely changed in 
the upcoming years. However, unlike in other situations, it is important to 
understand that unlike other disciplines this system of “push and pull” and “trial 
and error” involves human life.  Therefore it would behoove all parties involved to 
exercise caution in their decisions.   In order to do this, it is essential that we 
understand the history of bioethics, what has and hasn’t worked, so that we may 
give appropriate weight to each actor, learn from the past what has and hasn’t 
worked, and use these lessons in the revision of the system. 
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Where are We Now?  
 
“The scientists of the world must remember that the research is being done 
for the sake of mankind and not for the sake of science; scientists must 
never detach themselves from the humans they serve.”  
-Eva Kor, Mengele twin 
 
  
Understanding the history of the IRB process as well as the documents 
and events leading to its creation is essential to any discussion of issues in 
medical ethics.  Current policies aim to address past failures; current issues 
underline the problems that remain in the current system. By studying the history 
of medical ethics, one can get a grasp on the different interactions and ideas that 
have led to the modern system.  We can see what did and didn’t work, and from 
that gain guidance for future action.  
There are several important lessons we can learn from the history of 
biomedical research.  The history shows that while policies and systems can be 
changed, it is often necessary for the revelation of some great breach of medical 
ethics to occur before action is taken.  Such was the case for both the 
Nuremberg Code and the Belmont Report.  History shows that the backlash 
against these events is often large, vocal, and easily forgotten.  This can be seen 
with the unethical experiments done within five years of the Nuremberg Trials.  
History shows the to the importance of having bioethical policies and emphasizes 
how essential collaboration with the medical profession is in order to ensure 
compliance to these policies.  
Past events provide copious evidence that ethics, especially in the case of 
biomedical research, is a matter of constant vigilance.   This is shown in the way 
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that, despite several different forms of rules and regulations, unethical events still 
emerge.  In a world in which science represents progress and power, where 
scientists are constantly pushed to produce and achieve, there are far more 
impetuses towards breaking and stretching the rules than adhering to them.  It is 
for this reason that the IRB process is not enough.  Doctors, medical ethicists, 
researchers and subjects must work to regulate and monitor the system. In order 
to do this, an understanding of the policies, their histories and the reasons they 
were created is essential. The continued study of what factors in our researchers, 
research environments, and ethical regulation systems make unethical decisions 
more likely should be guided by history. The research presented in the previous 
chapter is encouraging.  By identifying these issues and their causes we may 
begin to address them. Beginning this process now could prevent biomedical 
research from more severe breaches of medical ethics like those that have 
occurred in the past.    
  As a discipline, medicine has been struggling for as long as it has existed 
to foster within its members a commitment to ethical conduct.  As a country, the 
United States has been working since World War II both nationally and 
internationally to establish a set of guidelines and a system that researchers and 
physicians will adhere to. However, frequently, the worlds of biomedicine and 
bioethics have found themselves  in opposition to each other.  The Nuremberg 
Code failed because doctors refused to adhere to it.  The Declaration of Helsinki 
was replaced by the Belmont Code because of revelations that researchers in 
the United States were unethical despite it. Though the creation of the IRB 
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system introduced a certain amount of power to the ethical regulations laid out by 
the Code of Federal Regulations and the Belmont Code, increased opposition 
and disconnect to the structure, as well as unethical decision making has been 
observed.  Currently, increasing research pressure coupled with the inability of 
the process to directly address the roots of unethical decisions limit the impact 
and extent of our system.  The IRB process watches doctors closely, using an 
outside body to examine each experiment; even so, unethical research still 
occurs. Though it is apparent from the structure and content of the CFR that 
bioethics did make an attempt to learn from history by placing additional 
oversight on researchers, it also ignored historical evidence that any system 
made in opposition to physician/researcher ideas will ultimately fail. The policies 
created to address and create ethical research are dependent on the level of 
significance those they govern place on them. 
Historical knowledge of bioethics also serves as a constant reminder of 
the importance of the field. Today, with the fast paced research environment, 
there is reluctance to give principles such as informed consent the respect their 
ethical foundations demand.  Experiments such as the Nazi concentration camp 
experiments and the Tuskegee trials serve as a reminder that there are 
consequences to belittling these principles. Examination of the individuals 
involved revealed that they did not represent extremists or medical outsiders. 
The defendants at the Nuremberg Trials represented some of the top physicians 
and scientists in Germany at the time; few were described as sadistic or insane, 
only as passionate and committed to their research. Furthermore, there were 
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already discussions around and guidelines for biomedical experimentation and 
the rights of the individual in Germany before World War II. The specter of the 
actions of Nazi doctors serves as a reminder that these ethical principles and 
policies must be taken seriously.  
 The question then seems, taking these influences into account, along with 
a knowledge of the strengths and shortcomings of the current IRB process, 
where does bioethics stand? In his essay on the impact of the Nuremberg Code, 
Leonard Glantz (1992) writes,  
“The Nuremberg Code is an exclusively substantive document, 
whereas the federal regulations contain procedural safeguards.  
These safeguards are embodied primarily in IRB review and public 
scrutiny by requiring at least one member of the IRB to be from the 
community. The mere fact of such scrutiny and the risk of 
exposure deter unethical research.  However, such review acts as 
a safeguard only when the values of the reviewers are directed at 
protecting human well-being.  It is unlikely that IRB review in Nazi 
Germany would have led to more humane treatment of subjects” 
(p.199). 
 
Glantz argues that our current process only works to safeguard the rights of 
patients and ensure ethical research if researchers share these goals. Research 
has shown that the main source of ethical guidance for researchers is gained 
through their peers and mentors.  Their decisions are guided by what they 
perceive from the climate and environment of their laboratory and institution.  
Ethical policies, documents and review boards can only supplement and guide 
scientists.  Currently, the increases we see in pressure on researchers as well as 
the inability of the IRB to effectively relieve this pressure is correlated with an 
increased observation in unethical decision making.  Glantz argues that the IRB 
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process would have had no effect in Germany because the research culture in 
the concentration camps encouraged unethical research. Physicians and 
researchers were pressured to produce results that could aid Germany in the war 
effort, and they were told to do so by any means necessary.  The Nazi doctors 
believed strongly in their cause.  They were ready to present ethical reasons to 
justify their actions.   The extremes seen in their research, especially their 
neglect of the rights of their patients, come from a failure to give appropriate 
weight to individual rights versus the “greater good”. Their interest centered 
almost entirely on the progress of science; no consideration was given to the 
rights or care of their subjects. 
In cases of individual rights in biomedical research, the preservation of the 
ethics and the integrity of the patient ultimately falls on the researcher. 
Committees can be created to oversee experiments, laws and regulations can be 
enacted to guide committees, however, the end product depends on the 
commitment the researcher has to adhere to these guidelines and the protection 
of patient rights. The Nazi experiments are a reminder of how essential the 
preservation of these rights are. Elie Wiesel (1992), a survivor of the camps who 
wrote extensively about his experiences, says of the doctors, 
“They knew how to differentiate between good and evil.  Their sense of reality 
was impaired.  Human beings were not human beings in their eyes.  They were 
abstractions.  This is the legacy of the Nuremberg Tribunal and the Nuremberg 
Code.  The respect for human rights in human experimentation demands that we 
see persons as unique, as ends in themselves” (p. ix). 
  
Examining the history of bioethics shows that while each subsequent 
document does address past problems and attempt to use those changes to 
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promote more ethical research, ultimately there is very little to be done if 
researchers are unwilling to comply. Referencing the extensive Guidelines that 
were already in place in German biomedicine before the start of World War II, 
Sharon Perley et al. (1992) points out,  “The fact that such a governmental 
regulation actually existed, at a time when the Nazis were carrying out human 
experiments in an irresponsible manner in concentration camps underlines the 
irrelevance of legal regulations if they are not enforced by the authorities” (p. 
151).  Ulf Schmidt reiterates this in his own work saying,  
“What becomes apparent is that the political climate of the time is central not only 
to the efficiency with which medical ethics regulations are being introduced and 
disseminated, but, more importantly, to the extent to which the rules are actually 
being followed by medical professions, funding and state agencies” (2004, 
p.281). 
 
The extent to which these rules are being followed, even with the modern IRB 
system, is dependent on researchers.  However, in our current system, pressure 
is placed on researchers from all sides.  In many cases, the pressure to produce 
and follow the rules may overshadow the pressure to maintain an ethical 
environment; a researcher may be tempted to discount the impacts of performing 
research without high ethical standards and instead place the responsibility for 
ensuring ethical research solely on Institutional Review Boards.  The history of 
biomedical research shows how essential it is to have the researchers 
themselves committed to ethical decision making and to creating an ethical 
research environment. The history of biomedical research also shows the 
consequences when this is not done.  
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The goal of this thesis is not to draw direct parallels between the current 
state of biomedical research and experiments done by Nazi doctors during World 
War II.   Instead, it aims to use the events as an opportunity to gain insight into 
possible areas of weakness in the modern day system by drawing on the 
extreme.  One of the great advantages of the Nazi experiments is that seeing 
such a degree of disregard for human autonomy and life in a “civilized and 
advanced” country is difficult to ignore. The events provide strength to arguments 
for constant vigilance in the worlds of bioethics and biomedical research.  
The current system of bioethics is not enough.  Already, studies are 
showing cracks in the modern research system. Many suggest that the current 
procedures of oversight limit researchers and fail to address where these ethical 
decisions are made from.  IRB processes result in increased pressure on 
researchers to meet the standards set by the CFR for “ethical research”; 
however, the system simply sets guidelines and provides paperwork for meeting 
these standards. Many times this limits or slows the research process as well as 
distances researchers from the ethical decisions made in their experiments.  It 
fails to support or guide researchers in their decisions. As a result researchers 
are required to turn to their peers and mentors for guidance. Increasing pressure 
from funding sources only serve to exacerbate these issues. We know from an 
examination of the history that neglecting to place appropriate emphasis on the 
principles of medical ethics in the laboratory, at the heart of research, results in 
violations of individual rights.  It is for these reasons that it is essential we begin 
to identify, to discuss, and eventually to address these problems, instead of 
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letting the situation escalate further. The commitment to the protection of 
individual rights and principles of ethics in biomedical research is essential to the 
preservation of our “humanity”. Without it, the discipline becomes a sad irony; a 
science striving for the advancement of society through methods that harm its 
subjects.  
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Epilogue 
 
 There is one factor in the Nazi experiments as well as other subsequent 
breaches in medical ethics that I feel it is important to identify but difficult to 
discuss within the scope of this thesis.  That is the role that war and “wartime 
conditions” plays in the way we weigh the tension between individual rights and 
actions for the “greater good” in medical experimentation. The Nazi experiments 
serve as a particularly well fitted example of one way acting in the interests of 
one’s country has been used by both governments and scientists in the past as 
ethical justification for ignoring and knowingly violating medical ethics.   
Throughout the Nuremberg Doctors’ Trial, the defendants presented a 
number of arguments attempting to ethically justify their actions during the war.  
The argument that wartime conditions and protection of country took greater 
precedence than ethical policies, has borne repetition in recent years. In the 
second half of the 20th century, the United States Army performed experiments 
in which various doses of LSD were given to soldiers without their knowledge or 
consent.  For some, the effects of these experiments were permanently 
damaging and had lifelong effects on the mental health of the soldiers.  The 
justification given by the CIA and the US Army for these experiments pointed to 
reasons of national security.  (Annas, 1992, p. 216) In December of 1990, the 
Federal Drug Administration granted the Department of Defense a waiver from 
the informed consent requirements necessitated by the Nuremberg Code and all 
other existing law and regulations in order to allow the department to test 
unapproved drugs and vaccines on the soldiers involved in experiment Desert 
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Shield.  (Annas, 1992, p. 216).    The “wartime mentality” argument given by the 
American government is almost identical to one of the major defenses given by 
Nazi physicians at Nuremberg (Annas, 1992, p. 218).  
 When examining the events of Nazi Germany as well as other breaches 
of medical ethics, it is important to focus on the role that medicine played in 
perpetrating these atrocities.  In times of war, countries must unite against a 
greater force.  Individuals must act in coordination with each other to combat the 
greater threat.  However, it is in these cases especially that the lines in ethics 
may be blurred.  Individuals are asked to act on behalf of their country, and as a 
result, may not consider the ramifications of their actions in the same way—they 
are blinded to the rights and concerns of the individual and may instead begin to 
perceive the persons they are dealing with only as representatives of their 
countries, nothing more.  
There is unfortunately very little that can be done to prevent further 
transgressions through legislation.  During times of political turmoil, laws and 
rules tend to be broken.  This can be seen in the horrifying facts of the Nazi 
experiments or in the suspension of informed consent by the FDA.  However, 
efforts can be made by the medical community to prevent physician and 
researcher involvement in future conflicts.  The Nazi experiments are significant 
to medical ethics not because of the unbelievability of the atrocities committed, 
but because of the essential role that doctors played in these acts.  Without 
science, without medicine, these things could not have occurred in the same 
magnitude.   
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In order to prevent repetition, the medical community must recognize their 
obligations to ethics and the rights of the individual in all instances. By studying 
the history we may be able to identify warning signs, and possibly prevent future 
incidents.  Creation of a more ethical research environment may be able to help 
with this, as could explaining to researchers the historical precedents and 
significance of the role they play in safeguarding ethics in times of political 
uncertainty. Ultimately, as indicated in the rest of this piece, the most important 
part is preserving a constant vigilance over the position of ethics in the world of 
biomedical research.   
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